Format

Send to

Choose Destination
See comment in PubMed Commons below
MAbs. 2014 Jul-Aug;6(4):812-9. doi: 10.4161/mabs.29004. Epub 2014 Apr 24.

Opening the door to innovation.

Author information

1
Genmab; Utrecht, The Netherlands.

Abstract

Open innovation is the new buzz, with initiatives popping up left and right. Here, we give a personal perspective on a very successful, knowledge-driven innovation initiated in an academia- industry alliance, which culminated in technology platforms that enable the generation of therapeutic antibodies with novel properties. To start, we provide a general background on open innovation in the drug development field.

KEYWORDS:

Duobody technology; Fab-arm exchange; Open innovation; Technology platform; bispecific antibodies; drug development; immunotherapy

PMID:
24784437
PMCID:
PMC4171017
DOI:
10.4161/mabs.29004
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center